Virtual Incision's Robotic Surgery Device FDA Approved

Virtual Incision, a company in the cultivate (MD) portfolio, has received marketing authorization from the US FDA for the MIRA Surgical System (MIRA).

Maharashtra FDA Targets Unauthorized Cosmetics Units in Mumbai

Commissioner Abhimanyu Kale of the Maharashtra Food and Drug Administration (FDA) led a raid on Mumbai-based Raj Products' premises to tackle illicit activities in the cosmetics industry.

AbbVie and OSE Collaborate on OSE-230 Monoclonal Antibody for Chronic Inflammation

AbbVie Inc. and OSE Immunotherapeutics SA, a clinical-stage immunotherapy company, announced a strategic partnership to develop OSE-230, a monoclonal antibody designed to resolve chronic and severe inflammation, currently in pre-clinical development.

Roche Pharma Introduces Ocrevus For multiple Sclerosis Treatment in India

Roche Pharma India reported the launch of its blockbuster advancement drug, Ocrevus (ocrelizumab), for the treatment of multiple sclerosis (MS), growing its nervous system science portfolio to take special care of neglected needs of various...

Bitterroot Bio and Biotheus Sign Research Pact To Develop Bispecific Proteins

Bitterroot Bio, an innovator in imaginative medicines for cardiovascular ailments, and Biotheus, a trailblazer in monoclonal and multi-explicit immunizer configuration, reported a long term research coordinated agreement. This alliance will...

Eli Lilly To Introduce Obesity Drug in India Next year: Eli Lilly CEO

Eli Lilly anticipates to introduce its obesity drug tirzepatide in India as soon as the following year, David Ricks, the U.S. drugmaker's President added. "We're open to any way to reach more patients as long as it makes sense for the company...

© 2024 India Pharma Outlook. All Rights Reserved.